Pacific Biosciences of California, Inc. (PACB) Deferred Income Tax Expense (Benefit)

Pacific Biosciences of California, Inc. Deferred Income Tax Expense (Benefit)

Pacific Biosciences of California, Inc. (PACB) reported Deferred Income Tax Expense (Benefit) of -$546.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-25

• Pacific Biosciences of California, Inc. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $1.18M.
• Pacific Biosciences of California, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$546.00K.
• Pacific Biosciences of California, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$205.00K.
• Pacific Biosciences of California, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$11.42M.
• Pacific Biosciences of California, Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.